@jennifer-carroll thank you!
L
l2022
@l2022
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Options for HCPs to seamlessly access manufacturer HCP Portals -
Options for HCPs to seamlessly access manufacturer HCP PortalsIf I recall correctly, the PAAB 2.0 training included alternative options (beyond completing a full registration process) for HCPs to access manufacturer HCP Portals. E.g. I think there was an option for the Rep to provide an access code to the HCP. Can you please share all the options and share a link to the training resource that outlines these details? Thank you.
-
PAAB eFiles Tag and CEI Report 2023@jennifer-carroll Thank you for this update. Would you be able to share how the submissions are selected which get a CEI survey at the end?